Literature DB >> 8642576

Reactivity of various leishmanial antigens in a direct agglutination test and their value in differentiating post-kala azar dermal leishmaniasis from leprosy and other skin conditions.

A El Harith1, S Chowdhury, A Al-Masum, S Semião-Santos, P K Das, S Akhter, J C Vetter, I Haq.   

Abstract

A direct agglutination test (DAT) for the detection of post-kala azar dermal leishmaniasis (PKDL) was evaluated in conditions that simulate the disease clinically or immunologically. A reference strain of Leishmania donovani (LEM 1399), and antigen preparations from Leishmania isolates from Bangladeshi patients with post-kala azar dermal leishmaniasis or visceral leishmaniasis were used. A titre of at least 51,200 was obtained in tests of patients with PKDL with all three antigens, whereas a maximum titre of 1600 was recorded in patients with cutaneous leishmaniasis, mucocutaneous leishmaniasis or leprosy. Antigens from dermal isolates of L. tropica (LV 140) and L. braziliensis (LV 65) yielded titres of 1600-6400 in patients with PKDL. The lowest titre recorded in 70 patients tested with the homologous PKDL antigen was 409,600. In patients with leprosy, cutaneous leishmaniasis, syphilis, onchocerciasis, tuberculosis, blastomycosis or vitiligo, titres ranged from 100 to 1600. Tha DAT is better than current parasitological and histopathological methods for the diagnosis of PKDL in areas in which leprosy is co-endemic.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8642576     DOI: 10.1099/00222615-44-2-141

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  6 in total

1.  Potential of direct agglutination test based on promastigote and amastigote antigens for serodiagnosis of post-kala-azar dermal leishmaniasis.

Authors:  Ruchi Singh; B V Subba Raju; R K Jain; Poonam Salotra
Journal:  Clin Diagn Lab Immunol       Date:  2005-10

2.  Evaluation of enzyme-linked immunosorbent assay for diagnosis of post-kala-azar dermal leishmaniasis with crude or recombinant k39 antigen.

Authors:  P Salotra; G Sreenivas; A A Nasim; B V Subba Raju; V Ramesh
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

3.  Use of PCR for diagnosis of post-kala-azar dermal leishmaniasis.

Authors:  O F Osman; L Oskam; N C Kroon; G J Schoone; E T Khalil; A M El-Hassan; E E Zijlstra; P A Kager
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

4.  Parasite detection in patients with post kala-azar dermal leishmaniasis in India: a comparison between molecular and immunological methods.

Authors:  P Salotra; G Sreenivas; K R Beena; A Mukherjee; V Ramesh
Journal:  J Clin Pathol       Date:  2003-11       Impact factor: 3.411

Review 5.  Post kala-azar dermal leishmaniasis: A threat to elimination program.

Authors:  Mallikarjuna Rao Gedda; Bhawana Singh; Dhiraj Kumar; Abhishek Kumar Singh; Prasoon Madhukar; Shreya Upadhyay; Om Prakash Singh; Shyam Sundar
Journal:  PLoS Negl Trop Dis       Date:  2020-07-02

6.  Systematic Review into Diagnostics for Post-Kala-Azar Dermal Leishmaniasis (PKDL).

Authors:  Emily R Adams; Inge Versteeg; Mariska M G Leeflang
Journal:  J Trop Med       Date:  2013-07-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.